Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A biological classification of Huntington's disease: the Integrated Staging System
Sarah J. Tabrizi, Scott Schobel, Emily C. Gantman, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 7, pp. 632-644
Open Access | Times Cited: 181

Showing 1-25 of 181 citing articles:

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Clifford R. Jack, J. Scott Andrews, Thomas G. Beach, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5143-5169
Open Access | Times Cited: 538
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
Tanya Simuni, Lana M. Chahine, Kathleen L. Poston, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 178-190
Closed Access | Times Cited: 255
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria
Günter U. Höglinger, Charles H. Adler, Daniela Berg, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 191-204
Closed Access | Times Cited: 242
Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities
Sarah J. Tabrizi, Carlos Estevez‐Fraga, Willeke M. C. van Roon‐Mom, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 7, pp. 645-658
Open Access | Times Cited: 209
Proposal for a Biologic Staging System of Parkinson’s Disease
Lana M. Chahine, Kalpana Merchant, Andrew Siderowf, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 3, pp. 297-309
Open Access | Times Cited: 59
Autosomal dominant cerebellar ataxias: new genes and progress towards treatments
Giulia Coarelli, Marie Coutelier, Alexandra Dürr
The Lancet Neurology (2023) Vol. 22, Iss. 8, pp. 735-749
Open Access | Times Cited: 49
A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's Disease
Francisco Cardoso, Christopher G. Goetz, Tiago Mestre, et al.
Movement Disorders (2023) Vol. 39, Iss. 2, pp. 259-266
Open Access | Times Cited: 46
Long somatic DNA-repeat expansion drives neurodegeneration in Huntington disease
Robert E. Handsaker, Seva Kashin, Nora Reed, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 26
Long somatic DNA-repeat expansion drives neurodegeneration in Huntington’s disease
Robert E. Handsaker, Seva Kashin, Nora Reed, et al.
Cell (2025)
Open Access | Times Cited: 18
Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington’s disease decades before clinical motor diagnosis
Rachael I. Scahill, Mena Farag, Michael Murphy, et al.
Nature Medicine (2025)
Open Access | Times Cited: 6
Improving the Clinical Diagnostic Criteria for Genetically Confirmed Adult-Onset Huntington Disease
Ciaran Considine, Clare M. Eddy, Samuel Frank, et al.
Neurology Clinical Practice (2025) Vol. 15, Iss. 2
Closed Access | Times Cited: 4
Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington’s disease
Daniel O’Reilly, Jillian Belgrad, Chantal Ferguson, et al.
Molecular Therapy (2023) Vol. 31, Iss. 6, pp. 1661-1674
Open Access | Times Cited: 37
Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s disease
Amica Corda Müller-Nedebock, Marieke C. J. Dekker, Matthew J. Farrer, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 30
Huntington’s Disease Clinical Trials Corner: August 2023
Carlos Estevez‐Fraga, Sarah J. Tabrizi, Edward J. Wild
Journal of Huntington s Disease (2023) Vol. 12, Iss. 2, pp. 169-185
Open Access | Times Cited: 27
Defining Parkinson’s Disease: Past and Future
Kristína Kulcsarová, Matěj Škorvánek, Ronald B. Postuma, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s2, pp. S257-S271
Open Access | Times Cited: 14
Huntington disease – Update on ongoing therapeutic developments and a look toward the future
Cristina Sampaio
Parkinsonism & Related Disorders (2024) Vol. 122, pp. 106049-106049
Closed Access | Times Cited: 11
Huntington’s Disease: Latest Frontiers in Therapeutics
Joseph Saade, Tiago Mestre
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 8, pp. 255-264
Closed Access | Times Cited: 11
Identifying time patterns in Huntington’s disease trajectories using dynamic time warping-based clustering on multi-modal data
Alexia Giannoula, Audrey E. De Paepe, Ferrán Sanz, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Antisense oligonucleotide–mediated MSH3 suppression reduces somatic CAG repeat expansion in Huntington’s disease iPSC–derived striatal neurons
Emma L. Bunting, Jasmine Donaldson, Sarah A. Cumming, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 785
Closed Access | Times Cited: 1
Diffusion along Perivascular Spaces as a Marker for Glymphatic System Impairment in Huntington's Disease
Jin‐Hui Yin, LingXiao Cao, Yang Liu, et al.
Movement Disorders (2025)
Open Access | Times Cited: 1
Resting-state fMRI reveals longitudinal alterations in brain network connectivity in the zQ175DN mouse model of Huntington's disease
Tamara Vasilkovska, Mohit H. Adhikari, Johan Van Audekerke, et al.
Neurobiology of Disease (2023) Vol. 181, pp. 106095-106095
Open Access | Times Cited: 19
Genetic modifiers of repeat expansion disorders
Sangeerthana Rajagopal, Jasmine Donaldson, Michael Flower, et al.
Emerging Topics in Life Sciences (2023) Vol. 7, Iss. 3, pp. 325-337
Open Access | Times Cited: 19
Towards a Biological Definition of Parkinson’s Disease
Günter U. Höglinger, Charles H. Adler, Daniela Berg, et al.
(2023)
Open Access | Times Cited: 18
α-Synuclein: A Promising Biomarker for Parkinson’s Disease and Related Disorders
Taku Hatano, Ayami Okuzumi, Gen Matsumoto, et al.
Journal of Movement Disorders (2024) Vol. 17, Iss. 2, pp. 127-137
Open Access | Times Cited: 6
Mild cognitive impairment in Huntington’s disease: challenges and outlooks
K. A. Jellinger
Journal of Neural Transmission (2024) Vol. 131, Iss. 4, pp. 289-304
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top